7SVP
Structure of compound 34 bound to human Phospholipase D2 catalytic domain
Summary for 7SVP
Entry DOI | 10.2210/pdb7svp/pdb |
Descriptor | Phospholipase D2, 1-(1-{(2S)-1-[(3R,5R)-3,5-dimethylpiperazin-1-yl]-1-oxopropan-2-yl}piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one (3 entities in total) |
Functional Keywords | phosphodiesterase, hkd motif, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 292929.14 |
Authors | Metrick, C.M.,Chodaparambil, J.V. (deposition date: 2021-11-19, release date: 2023-01-25, Last modification date: 2023-10-25) |
Primary citation | May-Dracka, T.L.,Gao, F.,Hopkins, B.T.,Hronowski, X.,Chen, T.,Chodaparambil, J.V.,Metrick, C.M.,Cullivan, M.,Enyedy, I.,Kaliszczak, M.,Kankel, M.W.,Marx, I.,Michell-Robinson, M.A.,Murugan, P.,Kumar, P.R.,Rooney, M.,Schuman, E.,Sen, A.,Wang, T.,Ye, T.,Peterson, E.A. Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System Penetrance. Acs Med.Chem.Lett., 13:665-673, 2022 Cited by PubMed: 35450377DOI: 10.1021/acsmedchemlett.1c00682 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.9 Å) |
Structure validation
Download full validation report